Clinuvel Pharmaceuticals (UR9A.F) Q3 2023 Earnings

29AugConfirmed
Q1 2022
Q3 2022
Q1 2023
Q3 2023
0.07
0.12
0.17
0.22

Details

Expected EPS
0.22040554630882914
Actual EPS
0.22040554630882914
Surprise EPS
0
Surprise Percent
+0%

Description

Clinuvel Pharmaceuticals (UR9A.F) has reported earnings of 0.22040554630882914 per share for Q3 2023.

0 Comments

Share your thoughts